Study ID | Treatment 1 | Treatment 2 | Style | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Age (years) | Intervention | Receptor status | Prior therapy | n | Age (years) | Intervention | Receptor status | Prior therapy | ||||||||
Median | Range | ER+/PR+ | TN | Chemo | Hormono | Median | Range | ER+/PR+ | TN | Chemo | Hormono | ||||||
Norikazu Masuda 2017 [7] | 24 | 53 | 32–78 | Bev + Tax | 22 | 2 | 9 | 15 | 30 | 60 | 28–71 | Tax | 24 | 6 | 13 | 19 | RCT |
David Miles 2017 [8] | 239 | 55 | 28–85 | Bev + Tax | 200 | 39 | 116 | 92 | 242 | 56 | 28–77 | Tax | 203 | 39 | 118 | 105 | RCT |
Christoph Rochlitz 2016 [19] | 71 | 64 | 30–82 | Bev + Tax | 61 | 10 | 38 | NA | 68 | 62 | 29–81 | Bev + Cap+Cyc | 52 | 15 | 37 | NA | RCT |
Christoph Zielinski 2016 [12] | 266 | NA | NA | Bev + Tax | 205 | 60 | 142 | 50 | 265 | NA | NA | Bev + Cap | 201 | 64 | 143 | 43 | RCT |
A. Welt 2016 [16] | 295 | 63 | 34–88 | Bev + Cap+Vin | 233 | 61 | 195 | 169 | 297 | 61 | 29–85 | Bev + Cap | 236 | 61 | 193 | 171 | RCT |
O. Trédan 2016 [20] | 58 | 56 | 35–77 | Bev + Exm | 57 | 1 | 35 | 33 | 59 | 55 | 35–86 | Bev + Tax | 59 | 0 | 38 | 39 | RCT |
Denise A. Yardley 2015 [17] | 56 | 61 | 30–77 | Bev + Tax+Exr | 44 | 12 | 34 | 34 | 57 | 57 | 25–79 | Bev + Tax | 45 | 12 | 31 | 37 | RCT |
Veronique Dieras 2015 [18] | 56 | 57 | 32–75 | Bev + Tax+Tre | 45 | 9 | 10 | NA | 58 | 52 | 31–74 | Bev + Tax | 45 | 12 | 11 | NA | RCT |
Hans-Joachim Luck 2015 [15] | 111 | 57 | 31–78 | Bev + Tax+Cap | 111 | 0 | NA | NA | 116 | 57 | 31–80 | Bev + Tax | 116 | 0 | NA | NA | RCT |
S.W. Lam 2014 [13] | 156 | 56 | 32–76 | Bev + Tax+Cap | 133 | 23 | 90 | 82 | 156 | 56 | 34–74 | Bev + Tax | 132 | 24 | 89 | 76 | RCT |
Joseph Gligorov 2014 [14] | 91 | 49 | 24–80 | Bev + Tax+Cap | 66 | 25 | NA | NA | 94 | 54 | 24–77 | Bev + Tax | 73 | 21 | NA | NA | RCT |
Istvan Lang 2013 [11] | 279 | 59 | 48–65 | Bev + Cap | 212 | 67 | 176 | 171 | 285 | 59 | 49–64 | Bev + Tax | 222 | 63 | 180 | 175 | RCT |
Adam M. Brufsky 2011 [21] | 201 | 56 | 28–86 | Bev + Tax | 145 | 47 | NA | NA | 103 | 56 | 35–84 | Tax | 77 | 20 | NA | NA | RCT |
97 | 57 | 31–78 | Bev + Cap | 74 | 18 | NA | NA | 47 | 50 | 23–90 | Cap | 36 | 10 | NA | NA | RCT | |
Miguel Martin 2011 [22] | 97 | 55 | 44–66 | Bev + Tax | 78 | 19 | 64 | 64 | 94 | 53 | 43–63 | Tax | 75 | 19 | 62 | 56 | RCT |
91 | 55 | 44–66 | Mot + Tax | 73 | 18 | 60 | 58 | 94 | 53 | 43–63 | Tax | 75 | 19 | 62 | 56 | RCT | |
97 | 55 | 44–66 | Bev + Tax | 78 | 19 | 64 | 64 | 91 | 55 | 44–66 | Mot + Tax | 73 | 18 | 60 | 58 | RCT | |
David W. Miles 2010 [9] | 247 | 55 | 27–76 | Bev + Tax | 187 | 60 | 167 | 120 | 241 | 55 | 29–83 | Tax | 189 | 52 | 156 | 135 | RCT |
Robert Gray 2009 [10] | 368 | 56 | 29–84 | Bev + Tax | 223 | 120 | 244 | NA | 354 | 55 | 27–85 | Tax | 223 | 99 | 231 | NA | RCT |